Abstract
This phase I study was designed to determine the maximum tolerated dose (MTD) and toxicities of combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (5-FU) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Patients received two cycles of chemotherapy repeated every 4 weeks. Starting doses (dose level 0) were: docetaxel 60 mg/m(2), cisplatin 60 mg/m(2), and 5-day continuous infusion 5-FU 600 mg/m(2) per day. At least three patients were examined at each dose level before advancing to the next level. Nineteen male patients (median age, 59.5 years) were enrolled. Eighteen patients had previously untreated stage III or IV SCCHN and 1 had local relapse, rT4. In the 19 patients, the regimen was well tolerated, with neutropenia as the most common toxicity (grade 3; n = 11; grade 4; n = 1). Dose-limiting toxicity (DLT) was observed at the fifth dose level (docetaxel 70 mg/m(2), cisplatin 70 mg/m(2), 5-FU 750 mg/m(2) per day), when 1 patient developed grade 2 renal toxicity during the first course; another 2 patients had persistent neutropenia. These doses were thus deemed the MTD for the regimen. In the 18 assessable patients, the overall clinical response rate was 94% (17/18 pati...Continue Reading
Citations
Oct 21, 2006·Cancer Chemotherapy and Pharmacology·Hideaki KatoriTakahide Taguchi
Nov 11, 2006·Cancer Chemotherapy and Pharmacology·Hideaki KatoriKiichi Watai
Feb 17, 2009·Cancer Chemotherapy and Pharmacology·Mamoru TsukudaYukiko Yamashita
Dec 25, 2009·Cancer Chemotherapy and Pharmacology·Mamoru TsukudaMasanori Komatsu
Jan 14, 2011·Cancer Chemotherapy and Pharmacology·Makiko MoriSayaka Iwahana
Dec 1, 2007·The Journal of Laryngology and Otology·Y J ChoiC H Sohn
Mar 25, 2006·Future Oncology·Dirk Schrijvers, Jan B Vermorken
May 7, 2011·Human Cell·Minako SuzukiIzumi Mataga
May 24, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emilio FonsecaJuan Jesús Cruz
May 26, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Markus HambekRainald Knecht
Nov 8, 2016·Current Medical Research and Opinion·Nebi Serkan Demirciİbrahim Güllü
May 12, 2005·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Yoichi IkedaNorifumi Saito
Nov 18, 2006·Head & Neck·Mehran BaghiRainald Knecht
Feb 2, 2018·World Journal of Surgical Oncology·Manoj PandeyMohan Kumar
Apr 9, 2005·Current Opinion in Oncology·Dirk Schrijvers, Jan B Vermorken
Nov 15, 2006·Acta Oto-laryngologica·Hideaki Katori, Mamoru Tsukuda
Dec 22, 2005·The Oncologist·Marshall R Posner
Mar 27, 2012·Nihon Jibiinkoka Gakkai kaiho·Mamoru Tsukuda
Apr 2, 2014·Japanese Journal of Clinical Oncology·Masanori KomatsuNobuhiko Oridate